ID   ZEC-157
AC   CVCL_VT87
DR   CCRID; 4201PAT-CCTCC00894
DR   Wikidata; Q98136471
RX   Patent=CN106047815A;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C201693.
CC   Population: Chinese.
CC   Doubling time: ~22 hours (Patent=CN106047815A).
ST   Source(s): Patent=CN106047815A
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D12S391: 19,22
ST   D13S317: 10,11
ST   D16S539: 11,12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 31
ST   D2S1338: 17,24
ST   D3S1358: 15
ST   D5S818: 11
ST   D6S1043: 12,20
ST   D7S820: 9,12
ST   D8S1179: 10,12
ST   FGA: 24
ST   Penta D: 12
ST   Penta E: 15,18
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 14,20
DI   NCIt; C4024; Esophageal squamous cell carcinoma
DI   ORDO; Orphanet_99977; Squamous cell carcinoma of the esophagus
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   60Y
CA   Cancer cell line
DT   Created: 24-05-19; Last updated: 21-03-23; Version: 8
//
RX   Patent=CN106047815A;
RA   Su, Dan
RA   Xiong, Lei
RA   Mao, Wei-Min
RA   Zhou, Xin-Ming
RA   Ying, Li-Sha
RA   Xie, Zheng-Hua
RA   Wu, Jun-Zhou
RT   "Esophageal cancer cell line and application thereof.";
RL   Patent number CN106047815A, 26-Oct-2016.
//